
Spago Nanomedical AB (publ) (SPAGO.ST)
SPAGO.ST Stock Price Chart
Explore Spago Nanomedical AB (publ) interactive price chart. Choose custom timeframes to analyze SPAGO.ST price movements and trends.
SPAGO.ST Company Profile
Discover essential business fundamentals and corporate details for Spago Nanomedical AB (publ) (SPAGO.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Jan 2013
Employees
13.00
Website
https://spagonanomedical.seCEO
Mats Hansen
Description
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
SPAGO.ST Financial Timeline
Browse a chronological timeline of Spago Nanomedical AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 7 May 2025
Earnings released on 6 Feb 2025
EPS came in at -kr 0.02, while revenue for the quarter reached kr 617.00K.
Earnings released on 6 Nov 2024
EPS came in at -kr 0.03, while revenue for the quarter reached kr 485.00K.
Earnings released on 21 Aug 2024
EPS came in at -kr 0.03, while revenue for the quarter reached kr 459.00K.
Earnings released on 2 May 2024
EPS came in at -kr 0.03, while revenue for the quarter reached kr 350.00K.
Earnings released on 7 Feb 2024
EPS came in at -kr 0.04, while revenue for the quarter reached kr 731.00K, beating expectations by +46.20%.
Stock split effective on 6 Nov 2023
Shares were split 523:500, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 3 Nov 2023
EPS came in at -kr 0.04, while revenue for the quarter reached kr 271.00K, missing expectations by -89.16%.
Earnings released on 31 Jul 2023
EPS came in at -kr 0.04, while revenue for the quarter reached kr 114.00K, missing expectations by -92.40%.
Earnings released on 9 May 2023
EPS came in at -kr 0.07, while revenue for the quarter reached kr 88.00K.
Earnings released on 2 Feb 2023
EPS came in at -kr 0.06, while revenue for the quarter reached kr 142.00K.
Earnings released on 8 Nov 2022
EPS came in at -kr 0.05, while revenue for the quarter reached kr 397.00K.
Earnings released on 24 Aug 2022
EPS came in at -kr 0.11, while revenue for the quarter reached kr 304.00K.
Stock split effective on 8 Jun 2022
Shares were split 1013:1000, changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Apr 2022
EPS came in at -kr 0.12, while revenue for the quarter reached kr 211.00K.
Earnings released on 2 Feb 2022
EPS came in at -kr 0.14, while revenue for the quarter reached kr 99.00K.
Earnings released on 10 Nov 2021
EPS came in at -kr 0.12, while revenue for the quarter reached kr 195.00K.
Earnings released on 24 Aug 2021
EPS came in at -kr 0.14, while revenue for the quarter reached kr 267.00K.
Earnings released on 28 Apr 2021
EPS came in at -kr 0.09, while revenue for the quarter reached kr 100.00K.
Earnings released on 13 Apr 2021
EPS came in at -kr 0.07, while revenue for the quarter reached kr 175.00K.
Earnings released on 10 Nov 2020
EPS came in at -kr 0.07, while revenue for the quarter reached kr 67.00K.
Earnings released on 25 Aug 2020
EPS came in at -kr 0.09, while revenue for the quarter reached kr 1.51M.
SPAGO.ST Stock Performance
Access detailed SPAGO.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.